TIME (Tumor Immunity in the MicroEnvironment) classification based on tumor <i>CD274</i> (PD-L1) expression status and tumor-infiltrating lymphocytes in colorectal carcinomas

Tsuyoshi Hamada(Brigham and Women's Hospital), Shuji Ogino(Broad Institute), Mingyang Song(Guangzhou University), Teppei Morikawa(Dana-Farber Cancer Institute), Jeffrey A. Meyerhardt(CancerCare), T. Rinda Soong(University of Pittsburgh Medical Center), Xinmeng Jasmine Mu(Pfizer (United States)), Tyler S. Twombly(Harvard University), Annacarolina da Silva(Cornell University), Juhong Yang(Harvard University), Jonathan N. Glickman(Massachusetts General Hospital), Catherine J. Wu(Dana-Farber Cancer Institute), Marios Giannakis(Broad Institute), Charles S. Fuchs(University of Southern California), Levi A. Garraway(Broad Institute), Yohei Masugi(Tokai University), Katsuhiko Nosho(Harvard University), Jonathan A. Nowak(Brigham and Women's Hospital), Scott J. Rodig(Brigham and Women's Hospital), Keisuke Kosumi(Kumamoto University), Andrew T. Chan(Harvard University), Gordon J. Freeman(Dana-Farber Cancer Institute), Kana Wu(Harvard University), Sachet A. Shukla(The University of Texas MD Anderson Cancer Center), Reiko Nishihara(Harvard University), Li Liu(Shihezi University), Xuehong Zhang(Brigham and Women's Hospital), Mancang Gu(Zhejiang Chinese Medical University), Kentaro Inamura(Jichi Medical University), Hideo Koh(Harvard University), Yan Shi(Hebei Provincial Center for Disease Control and Prevention)
OncoImmunology
February 21, 2018
Cited by 59


Related Papers